AB216983
MCAAD-3, Near-infrared probe for imaging of amyloid plaques
Be the first to review this product! Submit a review
|
(2 Publications)
MW 282.34 g/mol, Purity >99%. Near-infrared probe for imaging of amyloid plaques in Alzheimer's disease. DANIR 2c analog that shows extended emission wavelength and significant reduced binding affinity to Aβ aggregates compared with DANIR 2c. In vivo imaging studies suggest that MCAAD-3 can penetrate the blood–brain barrier and label Aβ plaques in the brains of transgenic mice.
Properties and storage information
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in neuroscience 18:1325287 PubMed38406587
2024
The effect of human PBMCs immobilization on their Аβ42 aggregates-dependent proinflammatory state on a cellular model of Alzheimer's disease.
Applications
Unspecified application
Species
Unspecified reactive species
Kateryna Kot,Yurii Kot,Rustam Kurbanov,Hanna Andriiash,Olena Tigunova,Yaroslav Blume,Sergiy Shulga
Acta neuropathologica communications 10:153 PubMed36307888
2022
Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer's amyloid pathology.
Applications
Unspecified application
Species
Unspecified reactive species
Anastasiia A Stepanchuk,Megan L Morgan,Jeffrey T Joseph,Peter K Stys
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com